SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041003
Filing Date
2019-11-06
Accepted
2019-11-06 16:06:37
Documents
53
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-10q_20190930.htm 10-Q 2159557
2 EX-10.1 gern-ex101_136.htm EX-10.1 37832
3 EX-31.1 gern-ex311_8.htm EX-31.1 17412
4 EX-31.2 gern-ex312_7.htm EX-31.2 17432
5 EX-32.1 gern-ex321_10.htm EX-32.1 7646
6 EX-32.2 gern-ex322_9.htm EX-32.2 7629
  Complete submission text file 0001564590-19-041003.txt   6683719

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gern-20190930.xml EX-101.INS 1504999
8 XBRL TAXONOMY EXTENSION SCHEMA gern-20190930.xsd EX-101.SCH 33771
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20190930_cal.xml EX-101.CAL 43638
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20190930_def.xml EX-101.DEF 131049
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20190930_lab.xml EX-101.LAB 294740
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20190930_pre.xml EX-101.PRE 226124
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 191196293
SIC: 2834 Pharmaceutical Preparations